Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
LSE:0H9X
RESEARCH TOOLSreports
Holding GB:0H9X?
Track your performance easily
0H9X Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€32.50 - €42.53
Previous Close€42.04
Volume43.61K
Average Volume (3M)107.56K
Market Cap
€12.40B
Enterprise Value€19.95B
Total Cash (Recent Filing)€1.56B
Total Debt (Recent Filing)€7.90B
Price to Earnings (P/E)18.7
Beta1.04
Next Earnings
Feb 25, 2025EPS Estimate
€0.88Last Dividend Ex-Date
May 17, 2024Dividend Yield2.85%
Share Statistics
EPS (TTM)2.25
Shares Outstanding293,413,449
10 Day Avg. Volume296,091
30 Day Avg. Volume107,556
Standard Deviation0.09
R-Squared0.21
Alpha-0.00685
Financial Highlights & Ratios
Price to Book (P/B)1.78
Price to Sales (P/S)0.72
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€42.06Price Target Upside0.04% Upside
Rating ConsensusHold
Number of Analyst Covering14
Fresenius Medical Care AG & Co. KGaA News
Bulls Say, Bears Say
Bulls Say
EarningsFollowing EPS changes supported by increased profitability, the price objective was raised to €33 / ADR $17.
Product ImpactHV HDF is a good addition to Fresenius’ product lineup, improving health outcomes and financial results.
Product LaunchFresenius Medical Care will launch its 5008X machine in the US, enhancing its innovative product offerings.
Bears Say
Financial PerformanceFME would need to show a significant sustainable uptick in both Care Delivery’s and Care Enablement’s profitability to achieve its targets.
Growth ChallengesContinuous weak volume and lower contribution from value-based care offset pricing benefits, leaving only a 1.3% organic growth for Care Delivery.
Market ValuationThe stock currently trades on approximately 15 times P/E for 2024, which is seen as demanding given a projected 2% sales CAGR from 2024 to 2026 compared to the sector's 7%.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
19.60% Mutual Funds
<0.01% Other Institutional Investors
74.12% Public Companies and
Individual Investors
0H9X FAQ
What was Fresenius Medical Care AG & Co. KGaA’s price range in the past 12 months?
Fresenius Medical Care AG & Co. KGaA lowest share price was €32.50 and its highest was €42.53 in the past 12 months.
What is Fresenius Medical Care AG & Co. KGaA’s market cap?
Currently, no data Available
When is Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date?
Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date is Feb 25, 2025 which is in 94 days.
How were Fresenius Medical Care AG & Co. KGaA’s earnings last quarter?
Fresenius Medical Care AG & Co. KGaA released its earnings results on Nov 05, 2024. The company reported €0.82 earnings per share for the quarter, beating the consensus estimate of €0.711 by €0.109.
Is Fresenius Medical Care AG & Co. KGaA overvalued?
According to Wall Street analysts Fresenius Medical Care AG & Co. KGaA’s price is currently Undervalued.
Does Fresenius Medical Care AG & Co. KGaA pay dividends?
Fresenius Medical Care AG & Co. KGaA pays a Annually dividend of €1.19 which represents an annual dividend yield of 2.85%. See more information on Fresenius Medical Care AG & Co. KGaA dividends here
What is Fresenius Medical Care AG & Co. KGaA’s EPS estimate?
Fresenius Medical Care AG & Co. KGaA’s EPS estimate is €0.88.
How many shares outstanding does Fresenius Medical Care AG & Co. KGaA have?
Fresenius Medical Care AG & Co. KGaA has 293,413,450 shares outstanding.
What happened to Fresenius Medical Care AG & Co. KGaA’s price movement after its last earnings report?
Fresenius Medical Care AG & Co. KGaA reported an EPS of €0.82 in its last earnings report, beating expectations of €0.711. Following the earnings report the stock price went up 0.788%.
Which hedge fund is a major shareholder of Fresenius Medical Care AG & Co. KGaA?
Currently, no hedge funds are holding shares in GB:0H9X
---
Fresenius Medical Care AG & Co. KGaA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€42.06 (0.04% Upside)
€42.06 (0.04% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.06%
12-Months-Change
Fundamentals
Return on Equity
4.77%
Trailing 12-Months
Asset Growth
-8.77%
Trailing 12-Months
Company Description
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
---
0H9X Stock 12 Month Forecast
Average Price Target
€42.06
▲(0.04% Upside)
Technical Analysis
Best Analysts Covering 0H9X
1 Year
1 Year Success Rate
17/37 ratings generated profit
1 Year Average Return
-2.03%
reiterated a sell rating 19 days ago
Copying James Vane's trades and holding each position for 1 Year would result in 45.95% of your transactions generating a profit, with an average return of -2.03% per trade.
---